Cover image of the article: The presence of anti-Toxoplasma antibodies in 50 donors and recipients of renal transplants

Image Credit:J Kermanshah Univ Med Sci

The presence of anti-Toxoplasma antibodies in 50 donors and recipients of renal transplants

Authors

Mahdi Vejdani1,*
1Dept. of Parasitology and Mycology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Mahdi Vejdani, Dept. of Parasitology and Mycology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran, E-mail: Email: mmvejdani@yahoo.com

Journal of Kermanshah University of Medical Sciences:Vol. 13, issue 1; e79829
Published online:Jun 19, 2009
Article type:Research Article
Received:Jul 09, 2008
Accepted:Apr 21, 2009
How to Cite:Vejdani M. The presence of anti-Toxoplasma antibodies in 50 donors and recipients of renal transplants. J Kermanshah Univ Med Sci. 2009;13(1):e79829. doi:

Abstract

Background: Toxoplasmosis is one of the prevalent parasitic diseases in the world with 10-40 percent of people having it as a latent infection. In cases of renal transplants, the condition either presents itself as a result of reactivation of the latent infection resulting in the weakness of immune system in a recipient or happens when a recipient simply contracts the condition from the donor through the organ transplant. The study examines IgM and IgG anti–toxoplasma antibodies in donors before the allograft and in recipients before and after the allograft.

Methods: For the purpose of this semi-experimental study, sera were collected twice from 50 donors and recipients, before the renal transplant and one month after it. The sera were examined by Enzyme Immunoassay (EIA) technique for detection of IgM and IgG antibodies. The data were then analyzed using standard deviation and T-test.

Results: The results revealed positive for IgG and IgM for 36% and 2% of the donors respectively. 52% of the recipients were proved IgG+ and 2% IgM+ before the allograft. In 54% of the recipients IgG antibodies was found after the allograft. 6% showed IgM anti- Toxoplasma in their sera after the allograft. Seroconversion in recipients before and after the allograft showed that the average increase in IgG in sera of recipients before the allograft was statistically significant (P <0.001).

Conclusion: Based on the results, IgG and IgM anti-Toxoplasma antibodies were present in the sera of donors before and recipients before and after the renal transplant. The existence of IgG anti-Toxoplasma in donors is not significant in terms of transmission. Yet its presence in recipients, in particular, as seroconversion may reflect latent toxoplasma-reactivaion. On the other hand, the presence of IgM in donors and recipients reveals a recent toxoplasmic involvement. It appears that immunosuppressive treatments result in reactivating latent tissue cysts and turning them into active toxoplasmosis.

Highlights

Fulltext

References

  • 1.
    The references of this article is available on PDF.

Copyright

© 2009, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

25
Sep
2012
Serological evaluation of anti-toxoplasma IgM and IgG antibodies in renal transplant recipient’s before and after transplant by ELFA, ELISA and ISAGA methods

Serological evaluation of anti-toxoplasma IgM and IgG antibodies in renal transplant recipient’s before and after transplant by ELFA, ELISA and ISAGA methods

Mohammad Javad Gharavi,
Sedigheh Jalali,
Shahram KhademVatan,
Soudabeh Heidari

Gharavi MJ, Jalali S, KhademVatan S, Heidari S. Serological evaluation of anti-toxoplasma IgM and IgG antibodies in renal transplant recipient’s before and after transplant by ELFA, ELISA and ISAGA methods. koomesh. 2012;13(2):e152506. doi:

31
Mar
2015
Screen of Uremic Patients for Toxoplasmosis Before Kidney Transplantation

Screen of Uremic Patients for Toxoplasmosis Before Kidney Transplantation

Fatemeh Hayati,
Shokouh Shayanpour

Hayati F, Shayanpour S. Screen of Uremic Patients for Toxoplasmosis Before Kidney Transplantation. Shiraz E-Med J. 2015;16(3):e26226. doi: https://doi.org/10.17795/semj26226

1
Oct
2013
Do we Need to Screen Uremic Patients for Toxoplasmosis before Kidney Transplantation?

Do we Need to Screen Uremic Patients for Toxoplasmosis before Kidney Transplantation?

Seyed Seifollah Beladi Mousavi,
Mohammad Faramarzi

Seifollah Beladi Mousavi S, Faramarzi M. Do we Need to Screen Uremic Patients for Toxoplasmosis before Kidney Transplantation?. Shiraz E-Med J. 2013;14(4):e18283. doi: https://doi.org/10.17795/semj18283

1
Nov
2013
Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran

Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran

Shahrzad Soltani,
Shahram Khademvatan,
Jasem Saki,
Heshmatollah Shahbazian

Soltani S, Khademvatan S, Saki J, Shahbazian H. Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran. Jundishapur J Microbiol. 2013;6(9):e7642. doi: https://doi.org/10.5812/jjm.7642

13
Nov
2013
Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR

Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR

Morteza Izadi,
Nematollah Jonaidi Jafari,
Abbas Mahmoodzadeh Poornaki,
Javid Sadraei,
Babak Rezavand,
Hamid Reza Mirzaei
,et al.

Izadi M, Jonaidi Jafari N, Mahmoodzadeh Poornaki A, Sadraei J, Rezavand B, et al. Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR. Nephro-Urol Mon. 2013;5(5):983-987. doi: https://doi.org/10.5812/numonthly.13657

More by these authors

Mahdi VejdaniPubMedScholar
Share
Cited by
Metrics